跳至主要内容
临床试验/NCT02564003
NCT02564003已完成不适用

Oxycodone Pharmacokinetics in Preterms, Infants and Children

Kuopio University Hospital0 个研究点目标入组 79 人开始时间: 2012年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
79
主要终点
Peak plasma concentration of oxycodone

研究概览

简要总结

The pharmacokinetics of oxycodone is well characterized in children older than six months of age. However, only one study has been published with children younger than six months, concluding that unexplained inter-individual variability is pronounced in the youngest children. The aim of the current study was to quantify oxycodone pharmacokinetics in children ranging from preterm newborn infants to children up to two years of age.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
— 至 2 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Infants scheduled for surgery with planned perioperative or postoperative opioid analgesia were screened if the gestational age (GA) was at least 23 weeks and postnatal age (PNA) below 2 years

排除标准

  • He/she had allergy or hypersensitivity to oxycodone or other ingredients in the formulations or had received monoamineoxidase, CYP3A (cytochrome P450 3A enzymes) or CYP2D6 (cytochrome P450 2D6 enzyme) inhibitors during the previous month or other reason that was considered to contraindicate participation.

研究组 & 干预措施

Oxycodone

Oxycodone 0,1 mg/kg iv

干预措施: Oxycodone (Drug)

结局指标

主要结局

Peak plasma concentration of oxycodone

时间窗: time zero hours to 24 hours

次要结局

未报告次要终点

研究者

发起方
Kuopio University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Merja Kokki

MD, Docent

Kuopio University Hospital

相似试验

Oxycodone Pharmacokinetics in Preterm Infants | 临床试验